Latest news with #MunjalShah
Business Wire
16-07-2025
- Business
- Business Wire
Hippocratic AI and Sheba Medical Center Partner to Transform Patient Care with Generative AI Integration
PALO ALTO, Calif. & RAMAT GAN, Israel--(BUSINESS WIRE)--Hippocratic AI, the global leader and pioneer in generative AI healthcare agents, today announced a partnership with Sheba Medical Center, a global beacon of medical innovation and research ranked by Newsweek as one of the top ten hospitals in the world. The partnership brings together Hippocratic AI's leading AI agent technology and Sheba's internationally acclaimed ARC (Accelerate, Redesign, Collaborate) Innovation Center to deploy safe, effective, and scalable AI solutions that transform healthcare delivery. Additionally, Hippocratic AI will join the ARC ecosystem, which is a global network consisting of leading hospitals, researchers, and innovation organizations. This ecosystem opens the door to new potential pathways for meaningful impact with others in the network. Hippocratic AI and Sheba are collaborating to advance their shared vision of creating a future of healthcare abundance by expanding access, enhancing quality, and improving the patient experience with empathetic, clinically rigorous AI that is both safe and effective. To date, healthcare providers have used Hippocratic AI GenAI healthcare agents to complete more than 2.49 million patient calls, earning an average patient satisfaction rating of 8.95 out of 10. 'Partnering with Sheba is an important step forward in realizing our mission to deliver safe, effective, high-quality generative AI healthcare at scale,' said Munjal Shah, Co-Founder and CEO of Hippocratic AI. 'Sheba's strong reputation for clinical excellence, and its innovation ecosystem at ARC make it the perfect partner to help us deliver transformative AI tools to providers and patients worldwide.' As part of its institutional vision to redefine the future of medicine, Sheba Medical Center is helping to drive the global shift toward AI-powered healthcare. Sheba combines clinical excellence with system-wide innovation, aiming to integrate safe, effective, and compassionate AI into real-world care at scale. This partnership with Hippocratic AI is part of Sheba's broader effort to become a fully AI-enabled health system and serve as a model for integrated responsible, patient-centered innovation. At the heart of this innovation is Sheba's ARC Innovation Center, a multidisciplinary model designed to transform healthcare by uniting clinicians, entrepreneurs, and researchers. Through this partnership, Hippocratic AI will integrate its generative AI agents to support non-diagnostic, patient-facing roles into Sheba's live clinical and research environments. Initial areas of collaboration include, but are not limited to, triage and patient intake. The agents will initially launch in English, followed by Hebrew in a later phase. With Sheba Medical Center recognized as one of the leading health systems in the Middle East, it serves as a global destination for patients seeking advanced, high-quality care. Sheba receives patients from both the region, including Jordan and Egypt, and beyond, delivering trusted, personalized treatment across a broad range of specialized services. Both organizations are guided by deeply aligned missions and values. Sheba's institutional mission is to deliver world-class medical care to all, regardless of background, religion, or nationality and to lead the way in cutting-edge research, innovation, and compassionate treatment. Its values include inclusivity, humanitarianism, and global impact. These principles align with Hippocratic AI's values to Do No Harm, Patients First, and providing Equal Access for All. "AI is transforming global health, and our partnership with Hippocratic AI supports Sheba's mission to become a fully AI-powered hospital," said Prof. Eyal Zimlichman, Founder and Director of ARC, and Chief Innovation, Transformation, and AI Officer at Sheba Medical Center. "Together, we are not just piloting a technology, but reimagining the way care is delivered – building a new clinical reality where intelligent, human-aligned systems work hand-in-hand with caregivers to elevate the standard of care worldwide." About Hippocratic AI Hippocratic AI has developed a safety-focused Large Language Model (LLM) for healthcare. The company believes that a safe LLM can dramatically improve healthcare accessibility and health outcomes in the world by bringing deep healthcare expertise to every human. No other technology has the potential to have this level of global impact on health. The company was co-founded by CEO Munjal Shah, alongside a group of physicians, hospital administrators, healthcare professionals, and artificial intelligence researchers from El Camino Health, Johns Hopkins, Stanford, Microsoft, Google, and NVIDIA. Hippocratic AI has received a total of $278 million in funding and is backed by leading investors, including Andreessen Horowitz, General Catalyst, Kleiner Perkins, NVIDIA's NVentures, Premji Invest, SV Angel, and six health systems. For more information on Hippocratic AI, About Sheba Medical Center The largest and most comprehensive medical center in the Middle East, Sheba Medical Center, Tel Hashomer is generating global impact through its medical care, research and healthcare transformation. Sheba's City of Health unities specialty hospitals, research and simulation centers, a virtual hospital, and ARC (Accelerate, Redesign, Collaborate), its innovation arm which connects entrepreneurs and clinicians to advance the development and implementation of new AI and tech solutions in healthcare, and accelerates the adoption of innovation both within the hospital and in health systems worldwide. Sheba is one of the top-ten hospitals in the world, having been ranked a World's Best Hospital by Newsweek for the last seven consecutive years (2019-2025). For more information, visit: or
Techday NZ
09-07-2025
- Business
- Techday NZ
KPMG & Hippocratic AI join forces to tackle healthcare shortages
KPMG and Hippocratic AI have formed a collaboration to address global healthcare workforce shortages by using AI-powered clinical digital agents to support healthcare professionals and improve operational efficiency. The healthcare sector around the world is currently facing workforce shortages, with estimates indicating a gap of approximately 10 million health workers projected by 2030. This shortage is contributing to increased pressure on existing staff and causing backlogs in healthcare delivery. To address these challenges, KPMG and Hippocratic AI are working together to deploy generative AI agents capable of performing non-diagnostic, patient-facing clinical tasks. Hippocratic AI, a company known for its development of generative AI healthcare agents, provides conversational agents that interact naturally with patients. These AI agents are designed to understand and respond in a contextually appropriate, human-like manner. By managing a variety of clinical workflows, including patient intake and post-care follow-up calls, the agents aim to free up healthcare providers' time, allowing more focus on direct patient care. KPMG's participation involves broad process analyses within healthcare organisations to identify operational bottlenecks. These studies seek to identify high-pressure points and pinpoint opportunities where AI can effectively augment existing staff. In addition to workforce upskilling, KPMG is also engaged in strategic planning for the deployment of AI technologies across the care continuum, aiming to improve productivity and patient outcomes while minimising disruption. Hippocratic AI's technology utilises its proprietary Polaris Constellation architecture, featuring large language models tailored to healthcare applications. According to the company, its generative AI agents have already completed more than 2.49 million patient calls, achieving an average patient satisfaction rating of 8.95 out of 10. These agents operate around the clock and can be scaled to meet demand, supporting healthcare professionals by handling communications that do not require clinical judgments or diagnoses. Emphasising the importance of purpose and alignment in this collaboration, Munjal Shah, Founder and Chief Executive Officer of Hippocratic AI, stated: "Hippocratic AI's collaboration with KPMG is deeply aligned in purpose and vision. Their holistic approach to digital and clinical transformation focuses on improving patient outcomes and optimising healthcare efficiency. We appreciate their commitment to driving meaningful impact across the entire care journey with generative AI, while preserving the human touch of clinicians and the integrity of healthcare operations." Dr. Anna van Poucke, KPMG Global Healthcare Leader, highlighted the growing challenge presented by healthcare workforce shortages as societies age. She commented: "As societies age, we are facing a critical healthcare workforce shortage that endangers the continuity of care. Hippocratic AI's generative AI healthcare agents can address such risks, however, to unlock their full value, a coherent and robust approach is needed to transform operational processes and upskill and empower clinical staff so the human workforce and their AI agent colleagues can operate in concert." Munjal Shah also remarked on the global applicability of Hippocratic AI's solutions, noting: "We have always thought that Hippocratic AI could benefit all sectors of healthcare worldwide and the tremendous success of the launch of our Gen AI agents among North American healthcare providers, clinicians, and patients, as well as our recent announcements in the UAE, Japan, and UK are strong indicators that we are on that path." A recent digital oncology solution supported by KPMG achieved a 50% increase in patient satisfaction, a 27% decrease in staff workloads, and a 78% increase in staff satisfaction, according to figures provided in the announcement. These results suggest measurable operational improvements when AI solutions are integrated into clinical practice and organisational workflows. The focus of the KPMG and Hippocratic AI joint initiative remains on deploying AI in ways that support healthcare professionals, relieve operational pressure, and maintain the quality and safety of patient care. Follow us on: Share on:
Business Wire
08-07-2025
- Business
- Business Wire
KPMG and Hippocratic AI Announce Collaboration to Transform Healthcare Delivery Using AI Healthcare Agents to Tackle Global Sector Staffing Shortages
LONDON--(BUSINESS WIRE)--Today KPMG International announces its innovative and timely work with healthcare technology company Hippocratic AI, global leader in developing safety-first generative AI healthcare agents that work alongside healthcare workers, performing non-diagnostic clinical tasks for patients. The international healthcare sector is experiencing a significant workforce shortage, with projections indicating a shortfall of approximately 10 million health workers by 2030. To help address this and relieve backlogs in healthcare systems worldwide, Hippocratic AI's generative AI agents safely conduct non-diagnostic patient-facing clinical tasks, marking a major milestone in addressing the global workforce shortage. KPMG global healthcare professionals are collaborating with Hippocratic AI to reimagine care delivery to support today's constrained healthcare workforce and create more efficient operational processes, ultimately alleviating overload on the workforce and improving patient outcomes. More specifically, KPMG is conducting broad process analyses to identify high-pressure points and upskill workforces to help best augment the workforce with AI and strategically plan for the highest-impact deployment of AI across the entire care continuum. Hippocratic's generative AI agents can free up provider time to focus on their patients using conversational agents designed to interact with humans in a natural, intuitive way as the agents comprehend, process, and respond to human conversation in a contextually relevant and human-like manner. Hippocratic AI's work represents a paradigm shift in how care is administered, signifying a move toward more abundant healthcare. Powered by its patented Polaris Constellation architecture, which features specialized large language support models, the generative AI healthcare agents can deliver a range of healthcare workflows from patient intake to care management follow-up calls. KPMG firms support by conducting broad process analyses to identify high-pressure points and upskill workforces to ensure human-AI alignment. This exercise enables KPMG firms to strategically plan the deployment of AI across the entire care continuum, effectively managing potential disruptions to achieve maximal value in productivity and patient outcomes. 'Hippocratic AI's collaboration with KPMG is deeply aligned in purpose and vision. Their holistic approach to digital and clinical transformation focuses on improving patient outcomes and optimizing healthcare efficiency. We appreciate their commitment to driving meaningful impact across the entire care journey with generative AI, while preserving the human touch of clinicians and the integrity of healthcare operations,' said Munjal Shah, Founder and CEO of Hippocratic AI. 'As societies age, we are facing a critical healthcare workforce shortage that endangers the continuity of care. Hippocratic AI's generative AI healthcare agents can address such risks, however, to unlock their full value, a coherent and robust approach is needed to transform operational processes and upskill and empower clinical staff so the human workforce and their AI agent colleagues can operate in concert,' said Dr. Anna van Poucke, KPMG Global Healthcare Leader. 'We have always thought that Hippocratic AI could benefit all sectors of healthcare worldwide and the tremendous success of the launch of our Gen AI agents among North American healthcare providers, clinicians, and patients, as well as our recent announcements in the UAE, Japan, and UK are strong indicators that we are on that path,' said Munjal Shah, Founder, and CEO of Hippocratic AI. Notes to editors: The joint effort between KPMG and Hippocratic AI is relatively new, and while KPMG firms are no strangers to AI-based solutions within healthcare, they have recently supported the creation of a broad 'digital oncology' solution. The digital service provided clinical information and contextual recommendations resulting in a 50% increase in patient satisfaction, 27% decrease in staff workloads and a 78% increase in staff satisfaction. To date, Hippocratic AI has completed more than 2.49 million patient calls, earning an average satisfaction rating of 8.95 out of 10. The Gen AI agents augment healthcare professionals by taking on non-diagnostic patient-facing communication, operating 24/7 with the capacity to scale. About Hippocratic AI Hippocratic AI has developed a safety-focused Large Language Model (LLM) for healthcare. The company believes that a safe LLM can dramatically improve healthcare accessibility and health outcomes in the world by bringing deep healthcare expertise to every human. No other technology has the potential to have this level of global impact on health. The company was co-founded by CEO Munjal Shah, alongside a group of physicians, hospital administrators, healthcare professionals, and artificial intelligence researchers from El Camino Health, Johns Hopkins, Stanford, Microsoft, Google, and NVIDIA. Hippocratic AI has received a total of $278 million in funding and is backed by leading investors, including Andreessen Horowitz, General Catalyst, Kleiner Perkins, NVIDIA's NVentures, Premji Invest, SV Angel, and six health systems. For more information on Hippocratic AI, About KPMG International KPMG is a global organization of independent professional services firms providing Audit, Tax and Advisory services. KPMG is the brand under which the member firms of KPMG International Limited ('KPMG International') operate and provide professional services. 'KPMG' is used to refer to individual member firms within the KPMG organization or to one or more member firms collectively. KPMG firms operate in 143 countries and territories with more than 275,000 partners and employees working in member firms around the world. Each KPMG firm is a legally distinct and separate entity and describes itself as such. Each KPMG member firm is responsible for its own obligations and liabilities. KPMG International Limited is a private English company limited by guarantee. KPMG International Limited and its related entities do not provide services to clients. For more detail about our structure, please visit
NHK
16-06-2025
- Business
- NHK
US startup to launch AI healthcare assistant in Japan
A US startup has announced plans to roll out an AI assistant in Japan to help ease the country's shortage of medical workers. Hippocratic AI CEO Munjal Shah said he hopes the AI will eventually be able to detect health risks faced by elderly patients and alert human staff. He added the program will be especially useful in Japan, which has one of the highest proportions of people over 65 in the world. "It's a place where you're going to need a lot more healthcare workers and the only real answer to this is going to be AI," said Shah. The AI assistant currently provides patients with non-diagnostic support. It can make appointments, monitor their condition after hospitalization, and manage medication. The company says the program is already being used by 2.5 million people around the world. Hippocratic AI entered a partnership with a Tokyo-based venture firm in May, with plans to make the AI assistant available in Japan later this year.
Business Wire
07-05-2025
- Business
- Business Wire
EUCALIA Inc. and Hippocratic AI Partner to Bring World's First Non-Diagnostic, Patient-Facing Japanese Generative AI Healthcare Agent to Market
PALO ALTO, Calif. & TOKYO--(BUSINESS WIRE)--Hippocratic AI, the global leader in safety-focused generative AI agents for healthcare, today announced a partnership with EUCALIA Inc., a Tokyo-based healthcare transformation company focused on optimizing clinical operations and advancing care delivery, to launch the first Japanese-language generative AI healthcare agent for non-diagnostic, patient-facing clinical tasks. This marks Hippocratic AI's entry into the Japanese market, further advancing its global mission to deliver healthcare abundance through technology. The Japanese generative AI healthcare agent, to be introduced this year, is designed to support clinicians by taking on time-consuming, but critical, non-diagnostic patient-facing tasks, such as appointment scheduling, follow-up outreach, chronic care check-ins, and medication adherence support. In a country facing growing healthcare demand, an aging population and a constrained clinical workforce, Hippocratic AI aims to increase clinician workflow efficiency and expand high-quality patient engagement with the goal of improving patient outcomes. 'This partnership with EUCALIA reflects our commitment to building generative AI agents that are not just multilingual but locally fluent, clinically safe, and culturally aligned. Japan's healthcare system is world-class but under strain, and we believe our technology can meaningfully extend its capacity without compromising quality or trust,' said Munjal Shah, CEO and Co-founder of Hippocratic AI. 'Together with EUCALIA, we're setting a new global benchmark for how generative AI can responsibly improve patient outcomes, enhance clinical operations at scale, and support a more resilient healthcare system for the people of Japan.' 'In Japan, a super-aging society, the shortage of clinicians and excessive workload are social issues that must be resolved urgently. EUCALIA's mission is to 'realize the ideal levels of care through transformation,' and we believe that if generative AI agents are introduced into the healthcare field, clinicians will be able to become more specialized and focus more on tasks that are unique to humans,' said Hideo Misawa, President and Representative Director of EUCALIA. 'We will initially introduce the system to medical institutions in Japan but will also explore a broader range of uses to contribute to building a society in which more people can live healthier lives.' The foundation for this generative AI healthcare agent is Hippocratic AI's Polaris Constellation System, a patented safety architecture purpose-built for safe, high-empathy healthcare conversations. The system has already powered more than 1.85 million patient calls in the U.S. and is deployed in over 25 enterprise healthcare partners. It has set a new benchmark in patient safety and satisfaction, achieving a clinical accuracy rate of 99.38% and a record-high patient experience rating of 8.95 out of 10. At the core of the Polaris constellation system are specialized supervisor models that oversee critical areas such as medications, labs and vitals, nutrition, escalation protocols, and hospital-specific policies. This collaboration reflects a shared commitment to support patients, reduce operational strain, and expand access to healthcare. By combining Hippocratic AI's proven technology and safety architecture with EUCALIA's deep understanding of Japan's healthcare landscape, the partnership will deliver a highly personalized, culturally aligned solution tailored to the needs of patients and providers in Japan. Together, the two organizations aim to create greater efficiency, empathy, and resilience in a system under pressure and advance the global vision of healthcare abundance. About EUCALIA EUCALIA is committed to transforming healthcare with its vision of the 'industrialization of healthcare.' By focusing on five core transformation themes, EUCALIA supports healthcare professionals in delivering more efficient and patient-centered care thorough: separation of medical care and management, optimization of hospital operations, pursuit of patient-driven value-based healthcare, comprehensive community model, and digital transformation in healthcare. To drive these transformations, EUCALIA provides comprehensive management and operational support, delivering solutions that are rooted in advanced digital technology. For more information on EUCALIA, About Hippocratic AI Hippocratic AI has developed a safety-focused Large Language Model (LLM) for healthcare. The company believes that a safe LLM can dramatically improve healthcare accessibility and health outcomes in the world by bringing deep healthcare expertise to every human. No other technology has the potential to have this level of global impact on health. The company was co-founded by CEO Munjal Shah, alongside a group of physicians, hospital administrators, healthcare professionals, and artificial intelligence researchers from El Camino Health, Johns Hopkins, Stanford, Microsoft, Google, and NVIDIA. Hippocratic AI has received a total of $278 million in funding and is backed by leading investors, including Andreessen Horowitz, General Catalyst, Kleiner Perkins, NVIDIA's NVentures, Premji Invest, SV Angel, and six health systems. For more information on Hippocratic AI, visit
